InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Canada IP Focus 2018

  • The first steps taken at the Canadian pharmaceutical patent dance

    J Bradley White and Nathaniel Lipkus of Osler analyse the changes introduced by the amendments to the PMNOC Regulations, examining the rules around the 24-month timeline for actions, appropriate parties in a proceeding, NOAs, early patent dismissals, confidentiality and the 24-month stay

  • Top five reasons to consider patent litigation in Canada

    Steve Garland and Jean-Sébastien Dupont of Smart & Biggar consider five reasons why carrying out patent litigation in Canada is preferable to US proceedings, including no opportunity for forum shopping, no jury trials and no inter partes reviews


More from the Managing IP blog


null null null

null

null null null

Most read articles

Supplements